ARCHIVES

FCRC Recompetition To Be Split Into Two Major Contract, For Research And “Everything Else”

This article is from The Cancer Letter archive.

Vol. 06 No. 35 | September 5, 1980

Download PDF Visit The Full Archive

Related Articles

Regulatory Approvals: Gardasil 9 approved, which covers five additional HPV types

December 12, 2014

Tell NCI About science, Not Funding Mechanisms, Broder Says to Society

January 21, 1994

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

NIH Panel Finds Older GI Imaging Tool Still Useful In Treating Pancreatic Diseases

February 22, 2002

ACS Adopts ‘Measures of Success’ To Mark Progress T0 Yr. 2000

April 17, 1992

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

June 17, 2011